Copaxone® in the Era of Biosimilars and Nanosimilars
نویسنده
چکیده
Jill B. Conner, MS, PhD,a Raj Bawa, MS, PhD,b,c J. Michael Nicholas, PhD,a and Vera Weinstein, PhDd aTeva Pharmaceutical Industries, Ltd., Specialty Life Cycle Initiatives, Global Specialty Medicines, Overland Park, Kansas, USA bBawa Biotech LLC, Ashburn, Virginia, USA cDepartment of Biological Sciences, Rensselaer Polytechnic Institute, Troy, New York, USA dTeva Pharmaceutical Industries, Ltd., Discovery and Product Development, Global Research and Development, Netanya, Israel
منابع مشابه
Physicochemical Characterization of Altebrel™, a Proposed Etanercept Biosimilar
Background: Etanercept is prescribed for the rapid and effective treatment of chronic immune-mediated inflammatory disorders. Due to the expiration of etanercept patents and worldwide demand for comparable and more affordable substitutes, several biosimilars of etanercept have been approved in different countries and new ones are in the process of approval.Objectives: In the present study...
متن کاملReviewing Shahid Beheshti University Scholars’ Presence in ResearchGate®
Background and Aim: Web 2.0 capabilities in research fields have provided numerous conveniences for scholars. This, has consent people to interact and share their publications with other scholars across the world. The purpose of the research is to study the presence of Shahid Beheshti University Scholars in ResearchGate. Method: Used approach in this paper is Scientometrics with Altmetrics met...
متن کاملDevelopment of statistics as a discipline for clinical research: Past, present and future
This article traces the history and evolution of statistics in the era of evidence based medicine, and focuses on the Indian perspective of this growth of statistics as a discipline for clinical research. Statistics will assume a more inter disciplinary form. Use of software other than SAS likely to grow further. In India, innovative statistical methods will help propel the development of biosi...
متن کامل